Icon Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $124K | Sell |
2,724
-13
| -0.5% | -$590 | 0.01% | 349 |
|
|
2023
Q2 | $112K | Sell |
2,737
-336
| -11% | -$13.8K | 0.01% | 388 |
|
|
2023
Q1 | $110K | Buy |
+3,073
| New | +$110K | 0.01% | 394 |
|
|
2021
Q3 | – | Sell |
-5,917
| Closed | -$236K | – | 347 |
|
|
2021
Q2 | $236K | Buy |
5,917
+246
| +4% | +$9.81K | 0.03% | 326 |
|
|
2021
Q1 | $255K | Buy |
5,671
+273
| +5% | +$12.3K | 0.03% | 289 |
|
|
2020
Q4 | $305K | Buy |
5,398
+648
| +14% | +$36.6K | 0.05% | 226 |
|
|
2020
Q3 | $225K | Buy |
4,750
+342
| +8% | +$16.2K | 0.04% | 235 |
|
|
2020
Q2 | $260K | Sell |
4,408
-340
| -7% | -$20.1K | 0.06% | 208 |
|
|
2020
Q1 | $224K | Sell |
4,748
-99
| -2% | -$4.67K | 0.09% | 132 |
|
|
2019
Q4 | $293K | Buy |
4,847
+909
| +23% | +$54.9K | 0.09% | 124 |
|
|
2019
Q3 | $236K | Buy |
3,938
+139
| +4% | +$8.33K | 0.08% | 133 |
|
|
2019
Q2 | $244K | Buy |
3,799
+945
| +33% | +$60.7K | 0.09% | 128 |
|
|
2019
Q1 | $232K | Sell |
2,854
-539
| -16% | -$43.8K | 0.09% | 135 |
|
|
2018
Q4 | $183K | Sell |
3,393
-120
| -3% | -$6.47K | 0.09% | 146 |
|
|
2018
Q3 | $181K | Sell |
3,513
-258
| -7% | -$13.3K | 0.08% | 182 |
|
|
2018
Q2 | $157K | Buy |
3,771
+133
| +4% | +$5.54K | 0.07% | 182 |
|
|
2018
Q1 | $160K | Buy |
3,638
+15
| +0.4% | +$660 | 0.09% | 187 |
|
|
2017
Q4 | $182K | Buy |
+3,623
| New | +$182K | 0.09% | 184 |
|